Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Patient Monitoring System Demand (Billion US$), 2014-2020
Figure 4-1: Medical Imaging Market Segmentation by Products (%), 2014
Figure 4-2: Medical Imaging Market Segmentation by Products (%), 2020
Figure 4-3: Medical Imaging Market (Billion US$), 2014-2020
Figure 4-4: Magnetic Resonance Imaging Market (Billion US$), 2014-2020
Figure 4-5: Ultrasound Imaging Market (Billion US$), 2014-2020
Figure 4-6: Computed Tomography (CT) Scanners Market (Billion US$), 2014-2020
Figure 4-7: X-Ray Systems Market (Billion US$), 2014-2020
Figure 4-8: IVD Products Market (Billion US$), 2014-2020
Figure 4-9: IVD Products Market by Clinical Segment (%), 2014
Figure 4-10: IVD Products Market by Clinical Segment (%), 2020
Figure 4-11: Immunoassay Diagnostics Market (Billion US$), 2014-2020
Figure 4-12: Clinical Chemistry Market (Billion US$), 2014-2020
Figure 4-13: Blood Testing Market (Billion US$), 2014-2020
Figure 4-14: Molecular Diagnostics Market (Billion US$), 2014-2020
Figure 4-15: Number of Diabetics in the US (Million), 2014 & 2030
Figure 4-16: Blood Glucose Monitoring Systems Market (Billion US$), 2014-2020
Figure 4-17: Cardiovascular Diagnostics Market (Billion US$), 2014-2020
Figure 4-18: Cancer Diagnostics Market (Billion US$), 2014-2020
Figure 5-1: Breakup of Clinical Lab Market by Services (%), 2014
Figure 5-2: Breakup of Outside Hospital Lab Services (%), 2014
Figure 5-3: Clinical Lab Services Market (Billion US$), 2014-2020

List of Tables:

Table 3-1: Life Expectancy and Prevalence of Diseases by Countries
Table 4-1: List of HIV Diagnostic Products
Table 6-1: Recent M&A in the US Diagnostics Market (2012 - 2015)
Table 7-1: Roche Holding Ltd. - Revenue by Business Segments (Million CHF), 2013 & 2014
Table 7-2: Roche Holding Ltd. - Strengths & Weaknesses
Table 7-3: Johnson & Johnson - Breakup of Medical Device Business (Million US$), 2013 & 2014
Table 7-4: Johnson & Johnson - Strengths & Weaknesses
Table 7-5: BioMerieux S.A. - Revenue by Business Segments (Million Euros), 2013 & 2014
Table 7-6: BioMérieux S.A. - Strengths & Weaknesses
Table 7-7: Siemens AG - Strengths & Weaknesses
Table 7-8: Becton Dickinson - Revenue by Business Segments (Million US$), 2013 & 2014
Table 7-9: Becton Dickinson - Strengths & Weaknesses
Table 7-10: Abbott Laboratories - Revenue by Business Segments (Million US$), 2013 & 2014
Table 7-11: Abbott Laboratories - Strengths & Weaknesses
Table 7-12: Beckman Coulter Inc. - Strengths & Weaknesses
Table 7-13: Hologic Inc. - Revenue by Business Segments (Million US$), 2013 & 2014
Table 7-14: Hologic Inc. - Strengths & Weaknesses
Table 7-15: QIAGEN - Strengths & Weaknesses
Table 7-16: Thermo Fisher Scientific Inc. - Revenue by Business Segments (Million US$), 2013 & 2014
Table 7-17: Thermo Fisher Scientific Inc. - Strengths & Weaknesses
Table 7-18: Quest Diagnostics Inc. - Strengths & Weaknesses
Table 7-19: Laboratory Corporation of America Holdings - Strengths & Weaknesses
Table 7-20: Genomic Health Inc. - Strengths & Weaknesses